Prestige Consumer Healthcare (PBH) Share-based Compensation Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.67% |
| Sep 30, 2025 | -42.04% |
| Jun 30, 2025 | 18.36% |
| Mar 31, 2025 | 42.88% |
| Sep 30, 2024 | -34.73% |
| Jun 30, 2024 | -17.39% |
| Dec 31, 2023 | 231.88% |
| Sep 30, 2023 | 6.41% |
| Jun 30, 2023 | 7.49% |
| Dec 31, 2022 | -183.12% |
| Sep 30, 2022 | 58.92% |
| Jun 30, 2022 | 32.27% |
| Mar 31, 2022 | 6.10% |
| Dec 31, 2021 | 40.68% |
| Sep 30, 2021 | -29.96% |
| Jun 30, 2021 | 134.78% |
| Mar 31, 2021 | -339.65% |
| Dec 31, 2020 | -10.79% |
| Sep 30, 2020 | 23.52% |
| Jun 30, 2020 | -10.07% |